Spectranetics sees FY13 EPS 0c-1c, consensus 9c Sees FY13 revenue $153M-$155M, consensus $152.35M. The projected net income includes impact of Medical Device Tax estimated to be approximately $2.5M. It also includes estimated non-cash amortization costs of $1.6M-$2M associated with the recently announced acquisition of the Quick-Access and Quick-Cross Capture devices. Sees FY13 adjusted EBITDA $13.M-$14.5M.
News For SPNC From The Last 14 Days
Check below for free stories on SPNC the last two weeks.